| TORCH | TOxoplasma, Rubella, Cytomegalovirus, Herpes, syphilis |
|---|---|
| CMV | continuous mandatory ventilation; controlled mechanical ventilation; conventional mechanical ventila... |
| CMV-MN | cytomegalovirus mononucleosis |
| HCMV | human cytomegalovirus |
| MCMV | murine cytomegalovirus |
| CMV | Anti-cytomegalovirus |
|---|---|
| HCMV | Anti-human cytomegalovirus |
| CMV | CYTOMEGALOVIRUS |
| CMV | Cytomegalovirus infection |
| CMVR | Cytomegalovirus retinitis |
| cytomegalovirus | <virology> Probably the most widespread of the Herpetoviridae group. Infected cells enlarge and have a characteristic inclusion body (composed of virus particles) in the nucleus. Causes disease only in utero (leading to abortion or stillbirth or to various congenital defects), although can be opportunistic in the immunocompromised host. Patients who have been exposed to the virus will remain cytomegalovirus IgG positive. Acronym: CMV (30 Sep 1997) |
|---|---|
| cytomegalovirus disease | <disease> An illness in newborns caused by viral infection, symptoms includefever, cellular enlargement, microscopically-visible clumps of viralparticles or proteins in the cytoplasm and nuclei of affected cells, enlargementof the spleen and liver. Long-term effects of the disease may includemental retardation. (09 Oct 1997) |
| cytomegalovirus infections | Infection with cytomegalovirus, characterised by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. (12 Dec 1998) |
| cytomegalovirus polyradiculopathy | <neurology, pathology> Cytomegalovirus infection of the peripheral nerves and the spinal roots leading to generalised weakness and paralysis. Origin: Gr. Pathos = disease (09 Oct 1997) |
| cytomegalovirus retinitis | <pathology> A complication of disseminated cytomegalovirus infection in the immunocompromised individual (for example AIDS). Severe inflammatory changes in the retina result in blindness. Treatments include antiviral agents like foscarnet and gancyclovir. (27 Sep 1997) |
| human cytomegalovirus | <virology> A group of viruses within the subfamily Cytomegalovirus (Betaherpesvirinae) (of the family Herpesviridae) which infects human beings. (09 Oct 1997) |
| aids vaccines | Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent aids. Some vaccines containing antigens are recombinantly produced. (12 Dec 1998) |
| bacterial vaccines | Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. (12 Dec 1998) |
| cancer vaccines | Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumour cells as the source of antigens, or using tumour-specific antigens, often recombinantly produced. (12 Dec 1998) |
| vaccines | Vaccines are microbial preparations of killed or modified microorganisms which can stimulate an immune response in the body in order to prevent future infection with similar microorganism. The smallpox vaccine has totally eliminated the smallpox disease from our planet. (12 Dec 1998) |
| vaccines, attenuated | Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. (12 Dec 1998) |
| vaccines, combined | Two or more vaccines in a single dosage form. (12 Dec 1998) |
| vaccines, conjugate | Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognised by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection. (12 Dec 1998) |
| vaccines, DNA | Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers. (12 Dec 1998) |
| vaccines, inactivated | Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins. (12 Dec 1998) |
Synonyms : Vaccines, Cytomegalovirus
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|